Chapter 11 Information (Details) Share data in Millions, except Per Share data, unless otherwise specified	0 Months Ended	1 Months Ended	3 Months Ended	25 Months Ended				3 Months Ended				3 Months Ended		3 Months Ended					12 Months Ended	1 Months Ended	3 Months Ended
	Sep. 21, 2012 USD ($)	Mar. 31, 2003 claim	Mar. 31, 2013 USD ($) trust claim committees	Dec. 31, 2010 occasion	Jun. 11, 2012 item	Mar. 31, 2012	Dec. 31, 2005	Mar. 31, 2013 PI Trust USD ($) trust	Mar. 31, 2013 PI and PD Trusts	Mar. 31, 2013 Personal Damage Trust [Member] USD ($) payment claim account	Mar. 31, 2003 Personal Damage Trust [Member] claim	Mar. 31, 2013 Cryovac, Inc. ("Cryovac") USD ($)	Mar. 31, 2013 Cryovac, Inc. ("Cryovac") Personal Damage Trust [Member] USD ($)	Mar. 31, 2013 Sealed Air Corporation ("Sealed Air")	Mar. 31, 2013 Sealed Air Corporation ("Sealed Air") PI Trust	Mar. 31, 2013 Fresenius Medical Care Holdings, Inc. USD ($)	Mar. 31, 2013 Fresenius Medical Care Holdings, Inc. Personal Damage Trust [Member] USD ($)	Jan. 31, 2011 Canada CAD	Dec. 31, 2009 Canada Personal Damage Trust [Member] claim	Oct. 31, 2008 United States (U.S.) Personal Damage Trust [Member] claim	Mar. 31, 2013 United States (U.S.) Personal Damage Trust [Member] claim	Mar. 31, 2013 PI and PD Committees committees	Mar. 31, 2013 PI and PD FCR committees	Mar. 31, 2013 Chapter 11 Filing Entities USD ($)		Dec. 31, 2012 Chapter 11 Filing Entities USD ($)
Chapter 11 information
Bankruptcy proceedings, number of committees			4																			2	2
ZAI property damage claim funds																		8,600,000
Asbestos trusts established under Bankruptcy Code			2					1
Number of occasions for which amendments and technical modifications were filed				9
Payments to fund Joint Plan												512,500,000				115,000,000
Interest rate related to cash received from the entity under joint plan funding (as a percent)								5.50%				5.50%
Number of common stock held in trust (in shares)															18
Common stock split arrangement														two-for-one
Number of claims expunged, reclassified by debtors or withdrawn by claimants					8
Number of pending claims			5
One-time payment to Libby claimants under the joint plan	19,600,000
Proceeds under Joint plan funding								250,000,000		152,000,000
Number of warrants issued by entity to fund trust (in shares)								10
Exercise price of warrant (in dollars per share)								$ 17.00
Expiration period of warrant								1 year
Deferred payments per year for five years by the entity to the Trust								110,000,000
Deferred payments per year for ten years by the entity to the Trust								100,000,000
Percentage of outstanding common stock issued in the event of default									50.10%
Percentage of claimed amount qualified for ZAI PD claims																					55.00%
Maximum resolved amount per claim										7,500
Number of PD Trust accounts										2
Proceeds from Joint Plan Funds, Equivalent of Estimated Expenses, Period										6 months
ZAI initial payment													30,000,000				30,000,000
Cash payment by entity to the Trust on the third anniversary of the effective date of the joint plan																	30,000,000
Maximum number of deferred payments by the entity to the Trust										10
Deferred payments per year for twenty years by the entity to the Trust										8,000,000
Minimum assets fulfilling condition for payment of contingent obligation by the entity to the Trust								10,000,000
Interest rate on pre-petition bank credit facilities (as a percent)			3.25%			3.25%	6.09%
Compound interest rate on unsecured claims (as a percent)			4.19%
Post-petition interest sought by general unsecured creditors			185,000,000
Percentage of shareholders on whom restrictions may be imposed for transfer of common stock			5.00%
Maximum acquisition percentage of common stock			4.75%
Warrant value settlement period after the effective date of the Joint Plan			1 year
Number of shares issuable under the warrant			10
Aggregate exercise price of the warrant			170,000,000
Closing price of common stock under condition 1 (in dollars per share)			$ 54.50
Repurchase price of warrant under condition 1			375,000,000
Closing price of common stock under condition 2 (in dollars per share)			$ 66.00
Repurchase price of warrant under condition 2			490,000,000
Period for change in control of the entity			1 year
Claims Filings
Number of claims filed		14,900								4,335									14,100
Number of pending claims, medical monitoring related		1,000
Number of claims filed after the bar date										800
Number of claims filed by employees or former employees			6,940
Number of claims filed by employees or former employees remaining pending			170
Bankruptcy Claims, Non Asbestos Related Pending Number		9,500								3,300	4,400
Number of remaining claims			115							20
Number of bankruptcy claims filed prior to a specified date																				17,960
Number of additional bankruptcy claims filed																					1,310
Cash-collateralized letter of credit facility			100,000,000
Estimated fair value available under the settlement			1,438,000,000
Asbestos related settlement in cash																115,000,000
Asbestos related settlement in cash and stock												1,323,000,000
Reclassification to current liabilities																								(10,400,000)	[1]	(10,100,000)	[1]
Due to Related Parties, Current																								5,900,000		6,000,000
Due to Other Related Parties, Noncurrent																								$ 21,700,000		$ 22,400,000

[1] As of March 31, 2013, and December 31, 2012, approximately $10.4 million and $10.1 million, respectively, of certain pension and postretirement benefit obligations subject to compromise have been presented in "other current liabilities" in the Consolidated Balance Sheets in accordance with ASC 715 "Compensation—Retirement Benefits".